Scott Braunstein, M.D.
Vice Chairman and Lead Independent Director Science and Technology Committee, Chair Audit Committee, Member
Scott is an operating partner at Aisling Capital and serves on the Board of Directors at both Caribou Biosciences, Inc. and Trevena Inc. Previously, Dr. Braunstein was Chief Executive Officer and Chairman of Marinus Pharmaceuticals, Inc, Chief Operating Officer at Pacira Pharmaceuticals, Inc. and portfolio manager of the JP Morgan Global Healthcare Fund. Dr. Braunstein began his career as a practicing physician at the Summit Medical Group, earning his medical degree from the Albert Einstein College of Medicine and his undergraduate degree from Cornell University.
Senior Leadership
Srinivas Rao, M.D., Ph.D.
Co-Founder and Chief Executive Officer
Anne Johnson
Chief Financial Officer
Gerd Kochendoerfer, Ph.D.
Chief Operating Officer
Robert Conley, M.D.
Chief Research and Development Officer
Kevin Craig, M.D.
Chief Medical Officer
Glenn Short, Ph.D.
Chief Scientific Officer
Ryan Barrett
Chief Legal and Business Officer
Board of Directors
Srinivas Rao, M.D., Ph.D.
Co-Founder and Chief Executive Officer
Christian Angermayer
Founder and Chairman
Scott Braunstein, M.D.
Vice Chairman and Lead Independent Director Science and Technology Committee, Chair Audit Committee, Member
Cosmo Feilding Mellen
Co-Founder and Director
Laurent Fischer, M.D.
Director Science and Technology Committee, Member Compensation Committee, Member
Rob Hershberg, M.D., Ph.D.
Board member
Andrea Heslin Smiley
Director Compensation Committee, Chair Nominating and Corporate Governance Committee, Member Audit Committee, Member
John Hoffman
Director
Amir Kalali, M.D.
Director Science and Technology Committee, Member Audit Committee, Member
Sabrina Martucci Johnson
Director Audit Committee, Chair Nominating and Corporate Governance Committee, Chair
